LI vs TCRX · P/E 24, rev $16.06B vs rev $2.0M
Li Auto Inc (LI) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Li Auto Inc (LI) is a auto manufacturers company listed on US. It is led by Xiang Li.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
LI currently screens at market cap $26.62B and trailing P/E 24.2. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the LI and TCRX stock pages for the full models.
Not investment advice.